Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Randomized Phase III Trial of Standard Therapy Plus Low Molecular Weight Heparin in Patients With Lung Cancer: FRAGMATIC Trial.

Macbeth F, Noble S, Evans J, Ahmed S, Cohen D, Hood K, Knoyle D, Linnane S, Longo M, Moore B, Woll PJ, Appel W, Dickson J, Ferry D, Brammer C, Griffiths G.

J Clin Oncol. 2016 Feb 10;34(5):488-94. doi: 10.1200/JCO.2015.64.0268. Epub 2015 Dec 23.

2.

Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.

Di Nisio M, Porreca E, Candeloro M, De Tursi M, Russi I, Rutjes AW.

Cochrane Database Syst Rev. 2016 Dec 1;12:CD008500. doi: 10.1002/14651858.CD008500.pub4. Review.

3.

TropicALL study: Thromboprophylaxis in Children treated for Acute Lymphoblastic Leukemia with Low-molecular-weight heparin: a multicenter randomized controlled trial.

Klaassen ILM, Lauw MN, van de Wetering MD, Biemond BJ, Middeldorp S, Abbink FCH, Bierings M, Te Loo DMMW, Pieters R, van der Sluis IM, Tissing WJE, Michel Zwaan C, Heleen van Ommen C.

BMC Pediatr. 2017 May 10;17(1):122. doi: 10.1186/s12887-017-0877-x.

4.

Meta-analysis on anticoagulation and prevention of thrombosis and mortality among patients with lung cancer.

Fuentes HE, Oramas DM, Paz LH, Casanegra AI, Mansfield AS, Tafur AJ.

Thromb Res. 2017 Jun;154:28-34. doi: 10.1016/j.thromres.2017.03.024. Epub 2017 Apr 1.

PMID:
28402864
5.

FRAGMATIC: a randomised phase III clinical trial investigating the effect of fragmin added to standard therapy in patients with lung cancer.

Griffiths GO, Burns S, Noble SI, Macbeth FR, Cohen D, Maughan TS.

BMC Cancer. 2009 Oct 6;9:355. doi: 10.1186/1471-2407-9-355.

6.

Pentasaccharides for the prevention of venous thromboembolism.

Dong K, Song Y, Li X, Ding J, Gao Z, Lu D, Zhu Y.

Cochrane Database Syst Rev. 2016 Oct 31;10:CD005134. Review.

PMID:
27797404
7.

Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.

Di Nisio M, Porreca E, Otten HM, Rutjes AW.

Cochrane Database Syst Rev. 2014 Aug 29;(8):CD008500. doi: 10.1002/14651858.CD008500.pub3. Review. Update in: Cochrane Database Syst Rev. 2016 Dec 01;12 :CD008500.

8.

Low molecular weight heparin in treating patients with lung cancer received chemotherapy: A meta-analysis.

Liu ZL, Wang Q, Wang M, Wang B, Huang LN.

J Cancer Res Ther. 2018 Jun;14(Supplement):S437-S443. doi: 10.4103/0973-1482.176174.

9.

Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.

Schoot RA, Kremer LC, van de Wetering MD, van Ommen CH.

Cochrane Database Syst Rev. 2013 Sep 11;(9):CD009160. doi: 10.1002/14651858.CD009160.pub2. Review.

PMID:
24026801
10.

Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial.

Lee AYY, Kamphuisen PW, Meyer G, Bauersachs R, Janas MS, Jarner MF, Khorana AA; CATCH Investigators.

JAMA. 2015 Aug 18;314(7):677-686. doi: 10.1001/jama.2015.9243. Erratum in: JAMA. 2017 Nov 28;318(20):2048.

PMID:
26284719
11.

Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.

Di Nisio M, Porreca E, Ferrante N, Otten HM, Cuccurullo F, Rutjes AW.

Cochrane Database Syst Rev. 2012 Feb 15;(2):CD008500. doi: 10.1002/14651858.CD008500.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;(8):CD008500.

12.

Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer.

Akl EA, Kahale L, Barba M, Neumann I, Labedi N, Terrenato I, Sperati F, Muti P, Schünemann H.

Cochrane Database Syst Rev. 2014 Jul 8;(7):CD006650. doi: 10.1002/14651858.CD006650.pub4. Review. Update in: Cochrane Database Syst Rev. 2018 Jun 19;6:CD006650.

PMID:
25004410
13.

Randomized phase III trial of low-molecular-weight heparin enoxaparin in addition to standard treatment in small-cell lung cancer: the RASTEN trial.

Ek L, Gezelius E, Bergman B, Bendahl PO, Anderson H, Sundberg J, Wallberg M, Falkmer U, Verma S, Belting M; Swedish Lung Cancer Study Group (SLUSG).

Ann Oncol. 2018 Feb 1;29(2):398-404. doi: 10.1093/annonc/mdx716.

14.

Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux or low molecular weight heparin in a large cohort of consecutive patients undergoing major orthopaedic surgery - findings from the ORTHO-TEP registry.

Donath L, Lützner J, Werth S, Kuhlisch E, Hartmann A, Günther KP, Weiss N, Beyer-Westendorf J.

Br J Clin Pharmacol. 2012 Dec;74(6):947-58. doi: 10.1111/j.1365-2125.2012.04302.x.

15.

Anticoagulation for the initial treatment of venous thromboembolism in people with cancer.

Hakoum MB, Kahale LA, Tsolakian IG, Matar CF, Yosuico VE, Terrenato I, Sperati F, Barba M, Schünemann H, Akl EA.

Cochrane Database Syst Rev. 2018 Jan 24;1:CD006649. doi: 10.1002/14651858.CD006649.pub7. Review.

PMID:
29363105
16.

Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair.

Forster R, Stewart M.

Cochrane Database Syst Rev. 2016 Mar 30;3:CD004179. doi: 10.1002/14651858.CD004179.pub2. Review.

PMID:
27027384
17.

Pentasaccharides for the treatment of deep vein thrombosis.

Brandao GM, Junqueira DR, Rollo HA, Sobreira ML.

Cochrane Database Syst Rev. 2017 Dec 2;12:CD011782. doi: 10.1002/14651858.CD011782.pub2. Review.

PMID:
29199766
18.

Low molecular weight heparin (LMWH) for primary thrombo-prophylaxis in patients with solid malignancies - systematic review and meta-analysis.

Ben-Aharon I, Stemmer SM, Leibovici L, Shpilberg O, Sulkes A, Gafter-Gvili A.

Acta Oncol. 2014 Sep;53(9):1230-7. doi: 10.3109/0284186X.2014.934397. Epub 2014 Aug 27. Review.

PMID:
25162954
19.

Vitamin K antagonists versus low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.

Andras A, Sala Tenna A, Stewart M.

Cochrane Database Syst Rev. 2017 Jul 24;7:CD002001. doi: 10.1002/14651858.CD002001.pub3. Review.

PMID:
28737834
20.

Treatment for superficial thrombophlebitis of the leg.

Di Nisio M, Wichers IM, Middeldorp S.

Cochrane Database Syst Rev. 2018 Feb 25;2:CD004982. doi: 10.1002/14651858.CD004982.pub6. Review.

PMID:
29478266

Supplemental Content

Support Center